Hib/MenC: patient group direction (PGD) template
PGD template to support the national Haemophilus influenzae type b and meningococcal C conjugate vaccination programme.
Applies to England
Documents
Details
This patient group direction (PGD) template supports the administration of Haemophilus influenzae type b (Hib) and meningococcal C conjugate vaccine to individuals from their first birthday to under 10 years of age in accordance with the national immunisation programme; and to individuals of any age for the prevention of secondary cases of meningococcal group C (MenC) disease in accordance with the Guidance for the public health management of meningococcal disease in the UK.
The Hib/MenC PGD version 05.00 is valid from 31 July 2022 to 1 August 2024 2024 and has been extended to 31 July 2025, when it is anticipated all centrally-held stocks of Menitorix® will be depleted. Further communication in respect of the changes to the childhood immunisation schedule will be received before this point.
Once locally held stocks are depleted and Menitorix® is no longer available from ImmForm, the authorising manager (as per section 7 of the PGD) should retire this PGD.
Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see ). Practitioners should follow local policy/procedures to access authorised PGD documents.
This PGD template should be used with reference to current national guidance, the Green Book, and for the vaccine.
Updates to this page
-
Added 'Notice of extension of the validity of Hib/MenC PGD'.
-
Added version 5.
-
Added V04.00: routine review.
-
Updated template to align with new guidance for the public health management of Meningococcal disease in the UK.
-
Updated to reflect removal of monovalent MenC from routine programme.
-
First published.